Post-approval studies (Phase 4)Study completedNCT01978262What this trial is testingImmune and Hormone Response to Influenza VaccineWho this might be right forHealthy Johns Hopkins Bloomberg School of Public Health 103
Large-scale testing (Phase 3)Study completedNCT05568797What this trial is testingA Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 1,045
Early research (Phase 1)Study completedNCT00722774What this trial is testingSafety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus VaccineWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00853255What this trial is testingGroup Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy AdultsWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT01342796What this trial is testingHumoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy SubjectsWho this might be right forSeasonal InfluenzaInfluenzaInfluenza Due to Unspecified Influenza Virus+1 more Novartis Vaccines 84
Not applicableStudy completedNCT05706350What this trial is testingPlant Stanol Esters and Influenza VaccinationWho this might be right forImmune Response Maastricht University Medical Center 137
Early research (Phase 1)Study completedNCT02151344What this trial is testingEvaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying IntervalsWho this might be right forInfluenza A Virus, H7N9 Subtype National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)Study completedNCT06501963What this trial is testingRevealing Protective Immunity to Influenza Using Systems ImmunologyWho this might be right forInfluenza Emory University 51
Early research (Phase 1)Study completedNCT00662272What this trial is testingSafety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 AdjuvantWho this might be right forInfluenza Colby Pharmaceutical Company 128
Not applicableLooking for participantsNCT03323112What this trial is testingImmune Responses in Health Care PersonnelWho this might be right forInfluenza Finnish Institute for Health and Welfare 150
Early research (Phase 1)Study completedNCT03186781What this trial is testingInfluenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT00992017What this trial is testingSafety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant WomenWho this might be right forHIV InfectionsH1N1 Influenza Virus National Institute of Allergy and Infectious Diseases (NIAID) 130
Testing effectiveness (Phase 2)Study completedNCT01578317What this trial is testingImmune Responses to H5N1 Vaccine With and Without AS03 AdjuvantWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 43
Early research (Phase 1)Study completedNCT00921206What this trial is testingStudy to Investigate the Immune Response to Two Doses of VAX102 Healthy AdultsWho this might be right forInfluenza VaxInnate Corporation 21
Not applicableStudy completedNCT00551837What this trial is testingImmune Response to Influenza VaccinationWho this might be right forSolid Organ TransplantationChronic Kidney Disease The Cleveland Clinic 82
Very early researchStudy completedNCT01518478What this trial is testingAtopic Dermatitis Research Network (ADRN) Influenza Vaccine PilotWho this might be right forAtopic Dermatitis National Institute of Allergy and Infectious Diseases (NIAID) 40
Post-approval studies (Phase 4)Study completedNCT03023176What this trial is testingT-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013Who this might be right forInfluenza Stanford University 20
Testing effectiveness (Phase 2)Study completedNCT00192309What this trial is testingPhase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.Who this might be right forInfluenza MedImmune LLC 31
Large-scale testing (Phase 3)Study completedNCT05045144What this trial is testingA Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.Who this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 1,586
Testing effectiveness (Phase 2)Study completedNCT06382311What this trial is testingFind and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older AdultsWho this might be right forInfluenza, Human GlaxoSmithKline 991